相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance
Stefany Moreno-Gamez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Evolutionary rescue: linking theory for conservation and medicine
Helen K. Alexander et al.
EVOLUTIONARY APPLICATIONS (2014)
Genomics of Rapid Adaptation to Antibiotics: Convergent Evolution and Scalable Sequence Amplification
David Laehnemann et al.
GENOME BIOLOGY AND EVOLUTION (2014)
Efficacy of Initial Antiretroviral Therapy for HIV-1 Infection in Adults: A Systematic Review and Meta-Analysis of 114 Studies with up to 144 Weeks' Follow-Up
Frederick J. Lee et al.
PLOS ONE (2014)
Loss and Recovery of Genetic Diversity in Adapting Populations of HIV
Pleuni S. Pennings et al.
PLOS GENETICS (2014)
Multi-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance
S. Alireza Rabi et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Molecular Characterization of Ambiguous Mutations in HIV-1 Polymerase Gene: Implications for Monitoring HIV Infection Status and Drug Resistance
Du-Ping Zheng et al.
PLOS ONE (2013)
Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure
Thibault Mesplede et al.
RETROVIROLOGY (2013)
Selective bird predation on the peppered moth: the last experiment of Michael Majerus
L. M. Cook et al.
BIOLOGY LETTERS (2012)
Evaluation of HIV-1 Ambiguous Nucleotide Frequency During Antiretroviral Treatment Interruption
Jonathan Z. Li et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
AD Model Builder: using automatic differentiation for statistical inference of highly parameterized complex nonlinear models
David A. Fournier et al.
OPTIMIZATION METHODS & SOFTWARE (2012)
The role of G protein gene GNB3 C825T Polymorphism in HIV-1 acquisition, progression and immune activation
Jennifer Juno et al.
RETROVIROLOGY (2012)
Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection
Roger D. Kouyos et al.
CLINICAL INFECTIOUS DISEASES (2011)
Genotypic resistance testing in routine clinical care
David T. Dunn et al.
CURRENT OPINION IN HIV AND AIDS (2011)
Evidence that Adaptation in Drosophila Is Not Limited by Mutation at Single Sites
Talia Karasov et al.
PLOS GENETICS (2010)
Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
Diane E. Bennett et al.
PLOS ONE (2009)
Relationship between Adherence Level, Type of the Antiretroviral Regimen, and Plasma HIV Type 1 RNA Viral Load: A Prospective Cohort Study
M. Martin et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
Forgiveness of non-adherence to HIV-1 antiretroviral therapy
Jonathan Shuter
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Rapid Experimental Evolution of Pesticide Resistance in C. elegans Entails No Costs and Affects the Mating System
Patricia C. Lopes et al.
PLOS ONE (2008)
The fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions
Mian-er Cong et al.
JOURNAL OF VIROLOGY (2007)
Adaptation to human populations is revealed by within-host polymorphisms in HIV-1 and hepatitis C virus
Art F. Y. Poon et al.
PLOS PATHOGENS (2007)
Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites
Shalini Nair et al.
MOLECULAR BIOLOGY AND EVOLUTION (2007)
Soft sweeps III: The signature of positive selection from recurrent mutation
Pleuni S. Pennings et al.
PLOS GENETICS (2006)
Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjects
JE Gallant et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Early virologic failure in a pilot study evaluating the efficacy of therapy containing once-daily abacavir, lamivudine, and tenofovir DF in treatment-naive HIV-infected patients
H Khanlou et al.
AIDS PATIENT CARE AND STDS (2005)
Impact of nelfinavir resistance mutations on in vitro phenotype, fitness, and replication capacity of human immunodeficiency virus type 1 with subtype B and C proteases
LMF Gonzalez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Human immunodeficiency virus reverse transcriptase and protease sequence database
SY Rhee et al.
NUCLEIC ACIDS RESEARCH (2003)
Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection
S Walmsley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
DDT resistance in Drosophila correlates with Cyp6g1 over-expression and confers cross-resistance to the neonicotinoid imidacloprid
P Daborn et al.
MOLECULAR GENETICS AND GENOMICS (2001)
Evolution - Humans as the world's greatest evolutionary force
SR Palumbi
SCIENCE (2001)
High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients
RW Shafer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
分享论文
